Cetera Trust Company N.A acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,054 shares of the company’s stock, valued at approximately $906,000.
Several other hedge funds have also recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC acquired a new position in Merck KGaA during the second quarter worth about $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $27,000. Solstein Capital LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $33,000. Burk Holdings LLC purchased a new position in shares of Merck KGaA during the 2nd quarter worth approximately $39,000. Finally, Bard Associates Inc. purchased a new position in shares of Merck KGaA during the 2nd quarter worth approximately $60,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
Merck KGaA Trading Up 0.1%
Shares of Merck KGaA stock opened at $163.45 on Tuesday. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The business has a 50 day moving average price of $162.78 and a 200 day moving average price of $148.59. The company has a market capitalization of $21.12 billion, a P/E ratio of 24.95 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
